GlobeNewswire

SEK CREDIT OPERATION ANNOUNCEMENT

Share
Bid date, 2021-01-11
Auction date2021-01-11
Settlement date2021-01-11
Maturity Date2021-04-12
Term13 weeks
Interest rateThe Riksbank´s applicable repo rate
Bid times11.00-11.30 (CET/CEST) on the Bid date
Confirmation of bids to e-maileol@riksbank.se
Offered volumeUnlimited
The lowest accepted bid volume50 million SEK
Maximum number of bids1
Allocation Time11.45 (CET/CEST) on the Bid date

Stockholm, 2021-01-11

Bid date, 2021-01-11
Auction date2021-01-11
Settlement date2021-01-11
Maturity Date2021-07-12
Term26 weeks
Interest rateThe Riksbank´s applicable repo rate
Bid times11.00-11.30 (CET/CEST) on the Bid date
Confirmation of bids to e-maileol@riksbank.se
Offered volumeUnlimited
The lowest accepted bid volume50 million SEK
Maximum number of bids1
Allocation Time11.45 (CET/CEST) on the Bid date

Stockholm, 2021-01-11

This is a translation of the Swedish version published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.


About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Allarity Therapeutics to test activity of its PARP inhibitor, stenoparib, as a potential therapy for new highly infectious Strain B.1.1.7 of Coronavirus26.1.2021 13:00:00 CETPress release

Press Release Hørsholm, Denmark (26 January 2021) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced plans to further test the antiviral activity of stenoparib, its PARP inhibitor, against SARS-CoV-2 lineage B.1.1.7, also known as Coronavirus Variant B117 (the “British variant”), at the Pathogen and Microbiome Institute at Northern Arizona University (NAU). The virus variant was labelled “Variant of Concern 202012/01” by Public Health England (PHE), an agency of the UK Department of Health & Social Care, in a publication on 21 December 2020, after it was found to have spread rapidly within the UK, and the PHE assessed that this variant has a substantially increased transmissibility compared with other Coronavirus variants. This variant has also been identified in the U.S. in several states. Based on the previous positive pre-clinical test results with stenoparib as a treatment of SARS-CoV-2, announced on 26 August 2020, Allarity Therapeutics will now test the sim

RESULT OF RIKSBANK REVERSED AUCTIONS SEK MUNICIPAL BONDS26.1.2021 11:30:00 CETPress release

Auction date2021-01-26Maturity2024Tendered volume, SEK mln1000 +/- 1000Offered volume, SEK mln0Volume bought, SEK mln0Number of bids0Number of accepted bids0 QuarterQuarter 1Quarter 2Quarter 3Quarter 4Offered volume, SEK mln0000Volume bought, SEK mln0000Number of bids0000Number of accepted bids0000Average yield, %----Lowest accepted yield, %----Highest yield, %----Accepted at lowest yield, %---- QuarterQuarter 1Quarter 2Quarter 3Quarter 4Offered volume, SEK mln0000Volume bought, SEK mln0000Number of bids0000Number of accepted bids0000Average yield, %----Lowest accepted yield, %----Highest yield, %----Accepted at lowest yield, %----

RCS users to grow 294% by 2024, driving new revenue for mobile operators26.1.2021 11:04:00 CETPress release

New report from Mobilesquared and Interop Technologies indicates that MNOs stand to gain a 240% revenue uplift over the forecast period by launching a native RCS solution LONDON, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Rich messaging is becoming a key platform connecting brands with consumers, joining the list of mainstream marketing channels alongside TV, the internet, and social media, according to the findings of a new report by business messaging intelligence experts, Mobilesquared. By the end of 2024 there will be more than 3 billion RCS users, representing an unparalleled growth rate of 294%. This high rate of growth is set to position RCS as the largest enhanced messaging platform globally and provide new revenue opportunities for mobile operators. The report, Safeguarding Revenue from A2P Messaging, published by Mobilesquared in partnership with Interop Technologies, highlights how RCS’ growth will help operators remain at the centre of mobile messaging. The only business messaging c

Maxihost Enables Next Generation Workloads with Powerful Ampere Processors26.1.2021 10:00:00 CETPress release

Collaboration brings high-performance Arm®-based microprocessors to Maxihost Bare Metal Cloud platform. SÃO PAULO, Brazil, Jan. 26, 2021 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=1iQ1BYMsZnun4xtGOTo7wF3uhR8iIyf3bFyT4GTQ5QNQKa8JTUZ1c3bOW2q5LvxkDvC7KwzrRHKVBbUaiu37zkCIYmJYQkua-fhz7qQH99M= Ampere® Computing, a developer of high-performance Arm®-based microprocessors for cloud and edge servers, and Maxihost, an innovative global provider of Bare Metal Cloud, are working together to enable on-demand bare metal access to Ampere’s energy-efficient, high-performance processors for the first time in South America. Access is also enabled for Maxihost clients in New York and Miami and will soon be available for clients in Los Angeles, Chicago, Dallas, Santiago and Sydney. Ampere processors deliver excellent total cost of ownership (TCO) value, high-performance compute, high-memory capacity, and rich I/O to address a broad range of workloads including application servers, cont

Nokia’s comprehensive C-Band portfolio ready for 5G build-out in U.S.26.1.2021 10:00:00 CETPress release

Press Release Nokia’s comprehensive C-Band portfolio ready for 5G build-out in U.S. Nokia’s complete C-Band solutions portfolio available for indoor and outdoor coverage Nokia C-Band solutions work across both 5G non-standalone and standalone networks; utilize latest AirScale infrastructureC-Band spectrum is a key resource for capacity and coverage capabilities of 5G networks 26 January 2021 Espoo, Finland – Nokia today announced that its enhanced C-Band portfolio will be available from Q1 2021 to support mobile operators’ 5G network deployments, following the conclusion of the recent spectrum auction in the U.S. Nokia’s comprehensive C-Band portfolio, which covers both indoor and outdoor deployment needs, includes massive MIMO antenna solutions, hybrid antennas that combine both passive and active radio platforms into a single, modular unit, macro remote radio heads and small cell solutions to cover all connectivity and deployment requirements. C-Band spectrum, between 3.4 GHz and 4.2

RadioMedix & Curium Announce Permanent HCPCS Code for DetectnetTM (copper Cu 64 dotatate injection)26.1.2021 08:30:00 CETPress release

St. Louis, MO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Detectnet a permanent Healthcare Common Procedure Coding System (HCPCS) code – A9592 – effective April 1, 2021. The descriptor for this product specific A code will be: Copper Cu-64, dotatate, diagnostic, 1 millicurie. Beginning on April 1, 2021, this code will be available to bill claims for Medicare patients in non-hospital imaging centers and for private insurance patients in all imaging facilities. This information follows the recent news that Detectnet was granted Transitional Pass-Through Status by CMS (C9068) effective January 1, 2021. C9068 is used to bill Detectnet for Medicare patients seen in the hospital outpatient department. “Once in effect, having both a permanent HCPCS code and Transitional Pass-Through Status will simplify the reimbursement process for all imaging centers that desire to us